Bio-Techne Corp. Stock
Bio-Techne Corp. Stock
Bio-Techne Corp. gained 0.290% compared to yesterday.
Bio-Techne Corp. is currently one of the favorites of our community with 18 Buy predictions and no Sell predictions.
However, we have a potential of -4.73% for Bio-Techne Corp. as the target price of 60 € is below the current price of 62.98 €.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Bio-Techne Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Bio-Techne Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
B****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Techne Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Techne Corp. | 0.290% | -0.095% | 0.994% | 25.960% | 25.960% | -18.208% | - |
| Haemonetics Corp. | 0.720% | 2.174% | 3.676% | - | 2.920% | - | - |
| CONMED Corp. | -0.530% | -2.094% | 19.872% | -10.952% | 6.857% | -66.000% | -66.903% |
| Penumbra Inc | 0.140% | 0.647% | 0.791% | 42.270% | 5.180% | 0.791% | 29.124% |
Comments
Bio-Techne (TECH) was upgraded by Evercore Inc from "hold" to "strong-buy".
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne (TECH) had its "buy" rating reaffirmed by TD Cowen.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne (TECH) had its price target lowered by Citigroup Inc. from $80.00 to $70.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat